Abstract
Inherited defects in cortisol biosynthesis are collectively termed congenital adrenal hyperplasia [reviewed in (1)]. Steroid 21-hydroxylase deficiency is, by far, the most common of these defects; it is reviewed elsewhere in this volume. This chapter reviews a related disease, steroid 11β-hydroxylase deficiency [reviewed in greater detail in (2)].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
White PC. Genetic diseases of steroid metabolism. Vitam Horm 1994; 49: 131–195.
White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta hydroxylase isozymes. Endocr Rev 1994; 15: 421–438.
Zachmann M, Tassinari D, Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab 1983; 56: 222–229.
Rosler A, Leiberman E, Cohen T. High frequency of congenital adrenal hyperplasia (classic 11 betahydroxylase deficiency) among Jews from Morocco. Am J Med Genet 1992; 42: 827–834.
Yanagibashi K, Haniu M, Shively JE, Shen WH, Hall P. The synthesis of aldosterone by the adrenal cortex. Two zones (fasciculata and glomerulosa) possess one enzyme for 11 beta-, 18-hydroxylation, and aldehyde synthesis. J Biol Chem 1986; 261: 3556–3562.
Mornet E, Dupont J, Vitek A, White PC. Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J Biol Chem 1989; 264:20, 961–20, 967.
Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, et al. Role of steroid 11 betahydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci USA 1992; 89: 1458–1462.
Cumow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu IL, Nadler JL, et al. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 1991; 5: 1513–1522.
Kawamoto T, Mitsuuchi Y, Ohnishi T, Ichikawa Y, Yokoyama Y, Sumitomo H, et al. Cloning and expression of cDNA for human cytochrome P-450aldo as related to primary aldosteronism. Biochem Biophys Res Commun 1990; 173: 309–316.
Ogishima T, Shibata H, Shimada H, Mitani F, Suzuki H, Saruta T, et al. Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism. J Biol Chem 1991; 266:10, 731–10, 734.
Curnow KM, Mulatero P, Emeric-Blanchouin N, Aupetit-Faisant B, Corvol P, Pascoe L. The amino acid substitutions Ser288Gly and Va1320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme [letter]. Nat Struct Biol 1997; 4: 32–35.
Chua SC, Szabo P, Vitek A, Grzeschik KH, John M, White PC. Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci USA 1987; 84: 7193–7197.
Wagner MJ, Ge Y, Siciliano M, Wells DE. A hybrid cell mapping panel for regional localization of probes to human chromosome 8. Genomics 1991; 10: 114–125.
Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, et al. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 1992; 89: 8327–8331.
Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 1992; 2: 66–74.
Waterman MR, Simpson ER. Regulation of steroid hydroxylase gene expression is multifactorial in nature. Recent Prog Horm Res 1989; 45: 533–563.
Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257: 1248–1251.
John ME, John MC, Boggaram V, Simpson ER, Waterman MR. Transcriptional regulation of steroid hydroxylase genes by corticotropin. Proc Natl Acad Sci USA 1986; 83: 4715–4719.
Wong M, Rice DA, Parker KL, Schimmer BP. The roles of cAMP and cAMP-dependent protein kinase in the expression of cholesterol side chain cleavage and steroid 11 beta-hydroxylase genes in mouse adrenocortical tumor cells. J Biol Chem 1989; 264: 12867–12871.
Kawamoto T, Mitsuuchi Y, Toda K, Miyahara K, Yokoyama Y, Nakao K, et al. Cloning of cDNA and genomic DNA for human cytochrome P-45011 beta. FEBS Lett 1990; 269: 345–349.
Morohashi K, Honda S, Inomata Y, Handa H, Omura T. A common transacting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 1992; 267: 17913–17919.
Rice DA, Mouw AR, Bogerd AM, Parker KL. A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 1991; 5: 1552–1561.
Hashimoto T, Morohashi K, Takayama K, Honda S, Wada T, Handa H, et al. Cooperative transcription activation between Adl, a CRE-like element, and other elements in the CYP11B gene promoter. J Biochem (Tokyo) 1992; 112: 573–575.
Honda S, Morohashi K, Omura T. Novel cAMP regulatory elements in the promoter region of bovine P-450(11 beta) gene. J Biochem (Tokyo) 1990; 108: 1042–1049.
Mouw AR, Rice DA, Meade JC, Chua SC, White PC, Schimmer BP, et al. Structural and functional analysis of the promoter region of the gene encoding mouse steroid 11 beta-hydroxylase. J Biol Chem 1989; 264: 1305–1309.
Rice DA, Aitken LD, Vandenbark GR, Mouw AR, Franklin A, Schimmer BP, et al. A cAMPresponsive element regulates expression of the mouse steroid 11 beta-hydroxylase gene. J Biol Chem 1989; 264: 14011–14015.
Kao CC, Lieberman PM, Schmidt MC, Zhou Q, Pei R, Berk AJ. Cloning of a transcriptionally active human TATA binding factor. Science 1990; 248: 1646–1650.
Meyer TE, Habener JF. Cyclic adenosine 3’,5’-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr Rev 1993; 14: 269–290.
Lala DS, Rice DA, Parker KL. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 1992; 6: 1249–1258.
Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993; 268: 7494–7502.
Levine LS, Rauh W, Gottesdiener K, Chow D, Gunczler P, Rapaport R, et al. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1980; 50: 258–263.
Honour JW, Anderson JM, Shackleton CH. Difficulties in the diagnosis of congenital adrenal hyperplasia in early infancy: the 11 beta-hydroxylase defect. Acta Endocrinol (Copenh) 1983; 103: 101–109.
Pang S, Levine LS, Lorenzen F, Chow D, Pollack M, Dupont B, et al. Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 1980; 50: 586–589.
New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, et al. Genotyping steroid 21hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 1983; 57: 320–326.
Lashansky G, Saenger P, Dimartino-Nardi J, Gautier T, Mayes D, Berg G, et al. Normative data for the steroidogenic response of mineralocorticoids and their precursors to adrenocorticotropin in a healthy pediatric population. J Clin Endocrinol Metab 1992; 75: 1491–1496.
Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, et al. Normative data for adrenal steroidogenesis in a healthy pediatric population: age-and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab 1991; 73: 674–686.
Harinarayan CV, Ammini AC, Karmarkar MG, Prakash V, Gupta R, Taneja N, et al. Congenital adrenal hyperplasia and complete masculinization masquarading as sexual precocity and cryptorchidism. Indian Pediatr 1992; 29: 103–106.
Bistritzer T, Sack J, Eshkol A, Zur H, Katznelson D. Sex reassignment in a girl with 11 betahydroxylase deficiency. Isr J Med Sci 1984; 20: 55–58.
Donahoe PK. Mullerian inhibiting substance in reproduction and cancer. Mol Reprod Dev 1992; 32: 168–172.
Hochberg Z, Schechter J, Benderly A, Leiberman E, Rosier A. Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Am J Dis Child 1985; 139: 771–776.
Birnbaum MD, Rose LI. Late onset adrenocortical hydroxylase deficiencies associated with menstrual dysfunction. Obstet Gynecol 1984; 63: 445–451.
Lucky AW, Rosenfield RL, McGuire J, Rudy S, Helke J. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab 1986; 62: 840–848.
Cathelineau G, Brerault JL, Fiet J, Julien R, Dreux C, Canivet J. Adrenocortical 11 beta-hydroxylation defect in adult women with postmenarchial onset of symptoms. J Clin Endocrinol Metab 1980; 51: 287291.
Brodie BL, Wentz AC. Late onset congenital adrenal hyperplasia: a gynecologist’s perspective. Fertil Steril 1987; 48: 175–188.
Rosler A, Leiberman E, Sack J, Landau H, Benderly A, Moses SW, et al. Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hormone Res 1982; 16: 133–141.
Mimouni M, Kaufman H, Roitman A, Morag C, Sadan N. Hypertension in a neonate with 11 betahydroxylase deficiency. Eur J Pediatr 1985; 143: 231–233.
Hague WM, Honour JW. Malignant hypertension in congenital adrenal hyperplasia due to 11 betahydroxylase deficiency. Clin Endocrinol (Oxf) 1983; 18: 505–510.
Griffing GT, Dale SL, Holbrook MM, Melby JC. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension. J Clin Endocrinol Metab 1983; 56: 218–221.
Ohta M, Fujii S, Ohnishi T, Okamoto M. Production of 19-oic-11-deoxycorticosterone from 19-oxo11-deoxycorticosterone by cytochrome P-450(11)beta and nonenzymatic production of 19-nor-11deoxycorticosterone from 19-oic-11-deoxycorticosterone. J Steroid Biochem 1988; 29: 699–707.
de Simone G, Tommaselli AP, Rossi R, Valentino R, Lauria R, Scopacasa F, et al. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension. Hypertension. 1985; 7: 204–210.
Donahoe PK, Powell DM, Lee MM. Clinical management of intersex abnormalities. Curr Probl Surg 1991; 28: 513–579.
Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178–182.
Nadler JL, Hsueh W, Horton R. Therapeutic effect of calcium channel blockade in primary aldosteronism. J Clin Endocrinol Metab 1985; 60: 896–899.
Resnick LM, Nicholson JP, Laragh JH. Calcium, the renin-aldosterone system, and the hypotensive response to nifedipine. Hypertension 1987; 10: 254–258.
Biollaz J, Durr J, Brunner HR, Porchet M, Gavras H. Escape from mineralocorticoid excess: the role of angiotensin II. J Clin Endocrinol Metab 1982; 54: 1187–1193.
White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rosler A. A mutation in CYP11B1 (Arg448-His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest 1991; 87: 1664–1667.
Helmberg A, Ausserer B, Kofler R. Frame shift by insertion of 2 basepairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab 1992; 75: 1278–1281.
Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA 1993; 90: 4552–4556.
Naiki Y, Kawamoto T, Mitsuuchi Y, Miyahara K, Toda K, Orii T, et al. A nonsense mutation (TGG [Trp1161-TAG [Stop] in CYP11B1 causes steroid l lbeta-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 77: 1677–1682.
Geley S, Kapelari K, Johrer K, Peter M, Glatzl J, Vierhapper H, et al. CYP11B1 mutations causing congenital adrenal hyperplasia due to 11(3-hydroxylase deficiency. J Clin Endocrinol Metab 1996; 81: 2896–2901.
Nelson DR, Strobel HW. On the membrane topology of vertebrate cytochrome P-450 proteins. J Biol Chem 1988; 263: 6038–6050.
Poulos TL. Modeling of mammalian P450s on basis of P450cam X-ray structure. Meth Enzymol 1991; 206: 11–30.
Ravichandran KG, Boddupalli SS, Hasemann CA, Peterson JA, Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450’s. Science 1993; 261: 731–736.
Johrer K, Geley S, Strasser-Wozak EM, Azziz R, Wollmann HA, Schmitt K, et al. CYP11B1 mutations causing nonclassic adrenal hyperplasia due to llb-hydroxylase deficiency. Hum Mol Genet 1997; 6: 1829–1834.
Azziz R, Boots LR, Parker CR Jr, Bradley E Jr, Zacur HA. 11 beta-hydroxylase deficiency in hyperandrogenism. Fertil Steril 1991; 55: 733–741.
Gibson M, Lackritz R, Schiff I, Tulchinsky D. Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women. Fertil Steril 1980; 33: 43–48.
Guthie GP, Wilson EM, Quillen DL, Jawad MJ. Adrenal androgen excess and defective 11-hydroxylation in women with idiopathic hirsutism. Arch Intern Med 1982; 412: 729–735.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
White, P.C. (2001). Steroid 11β-Hydroxylase Deficiency. In: Margioris, A.N., Chrousos, G.P. (eds) Adrenal Disorders. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-101-5_20
Download citation
DOI: https://doi.org/10.1007/978-1-59259-101-5_20
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-029-8
Online ISBN: 978-1-59259-101-5
eBook Packages: Springer Book Archive